Currency
Please select your currency.
Applications
Not sure what
you need?
Please contact us!
Expansion of human PSC
Derivation, reprogramming, expansion and differentiation of human embryonic stem cells and induced pluripotent stem cells in completely chemically defined, feeder-free and xeno-free conditions is robust on Biolaminin 521 expressed by hES and iPS cells.
| Product | Prod.no | Amount | Size | Price | Oty | |
|---|---|---|---|---|---|---|
Biolaminin 521 CTG
Human recombinant laminin 521 _________ SOLD OUT! Contact us to place an order for next LOT
|
CT521-0501 | 500 ug | 1 x 5 ml | €315 |
|
|
For larger quantities contact us |
|
|||||
SIZE GUIDENot sure how much laminin you need? To make it easy, we have created a tool where you can calculate the amount needed for your experiments. Just choose culture well format and fill in the desired coating concentration to see the amount required.
FORMAT
CONC. (ug/cm2).
NO OF WELLS
AMOUNT (uq)
|
||||||
| Product | Prod.no | Amount | Size | Price | Oty | |
|---|---|---|---|---|---|---|
Biolaminin 521 MX
Human recombinant laminin 521
|
MX521-0501 | 500 ug | 1 x 5 ml | €250 |
|
|
For larger quantities contact us |
|
|||||
SIZE GUIDE |
||||||
| Product | Prod.no | Amount | Size | Price | Oty | |
|---|---|---|---|---|---|---|
Biolaminin 521 LN
Human recombinant laminin 521
|
LN521-02 | 100 µg | 1 x 1 ml | €55 |
|
|
| LN521-05 | 500 ug | 1 x 5 ml | €210 |
|
||
| LN521-25 | 2,5 mg | 5 x 5 ml | €985 |
|
||
| LN521-175 | 17,5 mg | 35 x 5 ml | €5850 |
|
||
For larger quantities contact us |
|
|||||
SIZE GUIDE |
||||||
Terms & Conditions
For detailed information on BioLamina's Terms & Conditions, Disclaimer and Privacy Policy please click the links below.
Support
If you have any questions related to shipping, ordering, price or about BioLamina's products, please do not hesitate to contact us.
Local Distributors
Please contact our local distributors in Japan, China, Hong Kong and Macau, Singapore, Korea, Taiwan, India, Canada, Italy, Benelux, France, Australia and New Zealand.
